Loading...
BrainsWay Ltd.
BWAY•NASDAQ
Healthcare
Medical - Devices
$11.73
$-0.11(-0.93%)
BrainsWay Ltd. (BWAY) Financial Performance & Income Statement Overview
Review BrainsWay Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
29.04%
↑ 29.04%
Operating Income Growth
128.05%
↑ 128.05%
Net Income Growth
169.60%
↑ 169.60%
Operating Cash Flow Growth
702.02%
↑ 702.02%
Operating Margin
4.31%
↑ 4.31%
Gross Margin
74.51%
↑ 74.51%
Net Profit Margin
9.01%
↑ 9.01%
ROE
7.35%
↑ 7.35%
ROIC
2.25%
↑ 2.25%
BrainsWay Ltd. (BWAY) Income Statement & Financial Overview
Review BrainsWay Ltd.'s (BWAY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $11.41M | $10.50M | $10.005M | $9.10M |
| Cost of Revenue | $2.90M | $2.78M | $2.47M | $2.28M |
| Gross Profit | $8.51M | $7.72M | $7.54M | $6.81M |
| Gross Profit Ratio | $0.75 | $0.74 | $0.75 | $0.75 |
| R&D Expenses | $2.04M | $1.81M | $1.71M | $1.63M |
| SG&A Expenses | $5.07M | $5.63M | $5.24M | $5.09M |
| Operating Expenses | $8.08M | $7.44M | $6.95M | $6.72M |
| Total Costs & Expenses | $10.98M | $10.22M | $9.42M | $9.002M |
| Interest Income | $532000.00 | $830000.00 | $518000.00 | $618000.00 |
| Interest Expense | $174000.00 | $374000.00 | $401000.00 | $428000.00 |
| Depreciation & Amortization | $708000.00 | $448000.00 | $298000.00 | $317000.00 |
| EBITDA | $1.39M | $1.56M | $884000.00 | $410000.00 |
| EBITDA Ratio | $0.12 | $0.15 | $0.09 | $0.05 |
| Operating Income | $431000.00 | $281000.00 | $586000.00 | $93000.00 |
| Operating Income Ratio | $0.04 | $0.03 | $0.06 | $0.01 |
| Other Income/Expenses (Net) | $1.30M | $456000.00 | $117000.00 | $190000.00 |
| Income Before Tax | $1.74M | $737000.00 | $703000.00 | $283000.00 |
| Income Before Tax Ratio | $0.15 | $0.07 | $0.07 | $0.03 |
| Income Tax Expense | $188000.00 | $75000.00 | $103000.00 | $172000.00 |
| Net Income | $1.55M | $662000.00 | $600000.00 | $111000.00 |
| Net Income Ratio | $0.14 | $0.06 | $0.06 | $0.01 |
| EPS | $0.04 | $0.02 | $0.02 | $0.003 |
| Diluted EPS | $0.04 | $0.02 | $0.02 | $0.003 |
| Weighted Avg Shares Outstanding | $34.77M | $30.00M | $30.00M | $33.27M |
| Weighted Avg Shares Outstanding (Diluted) | $34.77M | $30.00M | $30.00M | $33.27M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan